Molecular cloning of lipocalin-2 into a eukaryotic vector and its expression inbovine mammary epithelial cells as a potential treatment for bovine mastitis

Thus, pIRES2-AcGFP1 was identified as an efficient vector for the delivery of the target gene to the mammary cells, and recombinant hLCN2 showed strong antibacterial activity against major mastitis-causing bacteria.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Lipocalin-2 (LCN2) is a 25-kDa protein in the lipocalin family that shows antibacterial activity.

📊

Key Findings & Data:The aim of this study was to clone human LCN2 into the mammalian-specific pIRES2-AcGFP1 vector and to determine the antibacterial activity of the recombinant pIRES2-AcGFP1-hLCN2 plasmid against major bacterial pathogens that cause bovine mastitis.

💡

Conclusion & Impact:Thus, pIRES2-AcGFP1 was identified as an efficient vector for the delivery of the target gene to the mammary cells, and recombinant hLCN2 showed strong antibacterial activity against major mastitis-causing bacteria.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Lipocalin-2 (LCN2) is a 25-kDa protein in the lipocalin family that shows antibacterial activity. The aim of this study was to clone human LCN2 into the mammalian-specific pIRES2-AcGFP1 vector and to determine the antibacterial activity of the recombinant pIRES2-AcGFP1-hLCN2 plasmid against major bacterial pathogens that cause bovine mastitis. The amplified hLCN2 was successfully cloned into the vector, and the plasmid was transfected into bovine mammary epithelial stem cells using nucleofection. Immunochemistry, reverse transcription polymerase chain reaction, and ELISA were used to monitor and quantify hLCN2 expression in the cells. After 1 day of incubation, the concentration of hLCN2 secreted by cells in the medium (6.85 ± 0.11 μg) was higher than that stored within the cells (22 ± 2.52 ng). After 4 days of culture, the amount of hLCN2 was 300-fold higher in the medium than within the cells. The recombinant clone showed potential antibacterial activity against mastitis-causing bacteria, with greater inhibitory activity against Escherichia coli than against Staphylococcus aureus. Antibacterial activity remained strong after 4-5 h of culture. Thus, pIRES2-AcGFP1 was identified as an efficient vector for the delivery of the target gene to the mammary cells, and recombinant hLCN2 showed strong antibacterial activity against major mastitis-causing bacteria.

🔖

Cite This Article

SHARMA, N., JEONG, D. K., SODHI, S. S., KIM, J. H., GHOSH, M., ZHANG, J. J., KOO, D., KANG, M. (2022). Molecular cloning of lipocalin-2 into a eukaryotic vector and its expression inbovine mammary epithelial cells as a potential treatment for bovine mastitis. Turkish Journal of Biology, Cilt: 40 - Sayı: 1, 55–68. https://ajindex.com/articles/600397

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Armacki M (2010). Identification and characterization of PKD2 substrates-CIB1A as a substrate for PKD2. PhD, Universitätsklinikum Ulm, Ulm, Germany.Berger T, Togawa A, Duncan GS, Andrew JE, You-Ten A, Wakeham A, Hannah EHF, Carol CC, Tak WM (2005). Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coliinfection but not to ischemiareperfusion injury. P Natl Acad Sci USA 106: 18341839.Bnyan IA, Bnyan HA, Ali JA (2010). The siderophore production of E. coli isolated from urinary tract infection and fecal isolates. J Babylon Univ/Pure Appl Sci 18: 862864.Cappuccino JG, Sherman N (1999). Microbiology: A Laboratory Manual. Boston, MA, USA: Addison Wesley Longman Inc.Chan YR, Liu JS, Pociask DA, Zheng M, Mietzner TA, Berger T, Mak TW, Clifton MC, Strong RK, Ray P et al. (2009). Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J Immunol 182: 49474956.Cowland JB, Borregaard N (1997). Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45: 17.Cowland JB, Sorensen OE, Sehested M, Borregaard N (2003). Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol 171: 66306639.Dale SE, Doherty-Kirby A, Lajoie G, Heinrichs DE (2004). Role of siderophore biosynthesis in virulence of Staphylococcus aureus: identification and characterization of genes involved in production of a siderophore. Infect Immun 72: 2937.de Souza BF (2011). Analysis of novel steroidogenic factor-1 targets in the human adrenal gland. PhD, University College London, London. Espitia PJP, Soares NFF, Teofilo RF, Vitor DM, Coimbra JSR, Andrade NJ, Sousa FB, Sinisterra RD, Medeiros EAA (2013). Optimized dispersion of ZnO nanoparticles and antimicrobial activity against foodborne pathogens and spoilage microorganisms. J Nanopart Res 15: 13241339.Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A (2004). Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432: 917921.Flower DR (1994). The lipocalin protein family: a role in cell regulation. FEBS Lett 354: 711.Friedl A, Stoesz SP, Buckley P, Gould MN (1999). Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues: cell type-specific pattern of expression. Histochem J 31: 433.Fukushima T, Allred BE, Sia AK, Nichiporuk R, Andersen UN, Raymon